Restructuring hitting pharmaceutical sector

Korea’s pharmaceutical sector is heading for a fresh round of restructuring, with many drug makers contemplating a plan to push employees to opt for early retirement plans amid growing worries over the lackluster earnings outlook.

Domestic drug firms are taking steps to reduce their workforces as they brace for lower earnings due to the government’s plan to slash drug prices starting April.
...